Integra LifeSciences Holdings Corp. (IART)
9.57
+0.03
(+0.31%)
USD |
NASDAQ |
Mar 25, 16:00
9.57
0.00 (0.00%)
After-Hours: 18:44
Integra LifeSciences Holdings Cash from Investing (Quarterly) : -34.91M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Baxter International, Inc. | -198.00M |
| Becton, Dickinson & Co. | -183.00M |
| Enovis Corp. | -12.99M |
| Stryker Corp. | -305.00M |
| Globus Medical, Inc. | -111.45M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 11.82M |
| Cash from Financing (Quarterly) | 24.34M |
| Free Cash Flow | -45.25M |
| Free Cash Flow Per Share (Quarterly) | -0.2516 |
| Free Cash Flow to Equity (Quarterly) | -46.92M |
| Free Cash Flow to Firm (Quarterly) | -30.98M |
| Free Cash Flow Yield | -6.15% |